| Bioactivity | Methyl 4-C-hydroxymethyl-2,3-O-isopropylidene-beta-D-ribofuranoside is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | Methyl 4-C-hydroxymethyl-2,3-O-isopropylidene-beta-D-ribofuranoside |
| CAS | 55797-67-6 |
| Formula | C10H18O6 |
| Molar Mass | 234.25 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
Methyl 4-C-hydroxymethyl-2,3-O-isopropylidene-beta-D-ribofuranoside
CAS: 55797-67-6 F: C10H18O6 W: 234.25
Methyl 4-C-hydroxymethyl-2,3-O-isopropylidene-beta-D-ribofuranoside is a purine nucleoside analog. Purine nucleoside ana
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.